David Shealy
41Patents
14h-index
23Co-inventors
81Inventor score
Filing activity: Jun 7, 1995 → Nov 1, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7250165B2 | Anti-TNF antibodies, compositions, methods and uses | Emerging Cross-Sectional Technologies | 187 | Expired |
| US6902734B2 | Anti-IL-12 antibodies and compositions thereof | Chemistry; Metallurgy | 83 | Expired |
| US7521206B2 | Anti-TNF antibodies, compositions, methods and uses | Emerging Cross-Sectional Technologies | 81 | Expired |
| US7560112B2 | Anti-il-6 antibodies, compositions, methods and uses | Chemistry; Metallurgy | 74 | Active |
| US8226611B2 | Anti-IL-6 antibodies, compositions, methods and uses | Chemistry; Metallurgy | 61 | Active |
| USRE43672E1 | Anti-IL-6 antibodies, compositions, methods and uses | General | 51 | Active |
| US7833755B2 | Anti-IL-6 antibody nucleic acid molecules and methods | Chemistry; Metallurgy | 49 | Active |
| US8623362B2 | Anti-IL-6 antibodies | Chemistry; Metallurgy | 48 | Active |
| US8067003B2 | Methods of treating conditions using anti-IL-6 antibodies | Chemistry; Metallurgy | 48 | Active |
| US7691378B2 | Anti-TNF antibodies, compositions, methods and uses | Emerging Cross-Sectional Technologies | 23 | Active |
| US7166285B2 | Anti-IL-12 antibodies and compositions | Chemistry; Metallurgy | 21 | Expired |
| US7063964B2 | Nucleic acids encoding IL-12 antibody | Chemistry; Metallurgy | 20 | Expired |
| US7279157B2 | Method for treating psoriasis by administering an anti-il-12 antibody | Chemistry; Metallurgy | 20 | Expired |
| US7560247B2 | Nucleic acids encoding anti-IL-12 antibodies, and methods of production | Chemistry; Metallurgy | 18 | Active |
| US9321836B2 | Anti-TNF antibodies, compositions, methods and uses | Emerging Cross-Sectional Technologies | 12 | Active |
| US8241899B2 | Anti-TNF antibodies, compositions, methods and uses | Emerging Cross-Sectional Technologies | 11 | Active |
| US7815909B2 | Anti-TNF antibodies, compositions, methods and uses | Emerging Cross-Sectional Technologies | 8 | Active |
| US9428579B2 | Method of treating Crohn's disease by administering an anti-IL-12 antibody | Chemistry; Metallurgy | 8 | Active |
| US8603778B2 | Anti-TNF antibodies, compositions, methods and uses | Emerging Cross-Sectional Technologies | 7 | Active |
| US10259867B2 | Method for treating lupus by administering an anti-IL-12 antibody | Chemistry; Metallurgy | 6 | Active |
| US8703141B2 | Method for treating Crohn's disease by administering an anti-IL-12 antibody | Chemistry; Metallurgy | 5 | Active |
| US8084233B2 | Nucleic acids encoding anti-IL-12 antibody | Chemistry; Metallurgy | 5 | Active |
| US8329171B2 | Method for treating psoriatic arthritis by administering an anti-IL-12 antibody | Chemistry; Metallurgy | 5 | Active |
| US9676848B2 | Anti-IL-12 antibodies and compositions | Chemistry; Metallurgy | 5 | Active |
| US7887807B2 | Anti-IL-12 antibodies and compositions | Chemistry; Metallurgy | 5 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.